Is Etanercept 25 mg Once Weekly as Effective as 50 mg at Maintaining Response in Patients with Ankylosing Spondylitis?:A Randomized Control Trial
Tools
Yates, Max, Hamilton, Louise E, Elender, Frances, Dean, Loretta, Doll, Helen, MacGregor, Alex J., Thomas, Joegi and Gaffney, Karl (2015) Is Etanercept 25 mg Once Weekly as Effective as 50 mg at Maintaining Response in Patients with Ankylosing Spondylitis?:A Randomized Control Trial. Journal of Rheumatology, 42 (7). pp. 1177-1185. ISSN 0315-162X
![]() |
PDF (Copyright-Transfer-April-2013)
Restricted to Repository staff only until 31 December 2099. Download (32kB) | Request a copy |
![]() |
Microsoft Word (FinalAnswersClean 10th Mar2015)
- Submitted Version
Download (73kB) |
Abstract
To investigate, in a pilot randomized controlled trial, whether etanercept (ETN) 25 mg once weekly is effective at maintaining a clinical response in patients with ankylosing spondylitis (AS) who have responded to the standard 50 mg dose.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | ankylosing spondylitis,anti-tumor necrosis factor therapy,etanercept,randomized control trial |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School Faculty of Medicine and Health Sciences > Allied Health Professions |
Depositing User: | Pure Connector |
Date Deposited: | 19 Aug 2015 15:16 |
Last Modified: | 19 Jan 2021 00:42 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/54126 |
DOI: | 10.3899/jrheum.141335 |
Actions (login required)
![]() |
View Item |